Pages

Sunday, May 6

April 2012 Review


Portfolio Update 
April saw some changes to the portfolio:
- Portfolio Redemption:  April is tax season in the US (and home improvement season in Mrs OM's mind!) and with this in mind Our Man and Mrs. OM decided earlier in the year to reduce their allocation to the portfolio at the end of Q1.  Given the large amount of cash in the portfolio and Our Man’s conviction in his names/theses, rather than selling positions to match the outflow, Our Man has reduced his cash position.  This has the impact of increasing the exposure to existing positions by c10%.
- NCAV Book changes:  As mentioned in the most recent NCAV post a number of positions within the NCAV bucket reached their sell-by date (see here for sell rules).  These positions were sold during April, leaving the NCAV portfolio with a solitary position.

Performance Review
April proved to be the portfolio’s first profitable month (+64bps) of the year though the portfolio is still negative for the year (-1.2% YTD).  While April saw the return of some uncertainty to the markets, which fell slightly over the course of the month, the portfolio’s profits were surprisingly broadly spread.

A number of books posted marginal gains/losses, which largely cancelled each other out.  The NCAV book (-4bps) was down for the month, though this largely represented the costs (mainly brokerage commissions) of exiting the majority of the portfolio.  The Currencies book (+7bps) benefited from the uncertainty in Europe and the China book (+2bps) from the mixed signals on Chinese growth.  The Puts/Hedges book (-5bps) was a mild detractor despite the small fall in equity markets

The Treasury Book (+21bps) and the Bond/Absolute Return Funds (+19bps) were both aided by the strengthening of US Treasuries over the course of the month, as uncertainty (especially over Europe) increased.  This uncertainty negatively impacted the Energy Efficiency book (-15bps) to a relatively large degree, given the speculative nature of one of the names (AXPW) and the mediocre recent history of another (XIDE).

The Value Equity book (+40bps), which has largely been disappointing to date, bucked the trend and had a strong month despite the small fall in the equity markets.  The performance was driven by the position in THRX, which rose after announcing that GlaxoSmithKline, its joint venture partner, was further increasing its stake in the business at a price above the then market value


Portfolio (as at 3/31 - all delta and leverage adjusted, as appropriate)
17.7% - Bond/Absolute Return Funds (DLTNX and HSTRX)
6.1% - Value Idea Equities (THRX, and DRWI)
4.5% - Treasury Bonds (TLT)
2.3% - Energy Efficiency (AXPW, and XIDE)
0.4% - NCAV Equities
0.0% - Other Equities (none)

-1.5% - China-Related Thesis (46bps premium in EWZ Jan-13 puts)
-2.4% - Hedges/Put Options (24bps in IWM Jan-13 puts, 20bps in SPY Jan-13 puts and 13bps XLY Jan-13 puts)

-10.7% - Currencies (EUO – Short Euro)

62.5% - Cash

Disclaimer:  For added clarity, Our Man is invested in all of the securities mentioned (TLT, DLTNX, HSTRX, THRX, DRWI, AXPW, XIDE, , EWZ puts, IWM puts, SPY puts, XLY puts, and EUO).  He also holds some cash.  You should not buy any of these securities because Our Man has mentioned them, but should do your own work and decide what’s best for you.

Saturday, May 5

Perception & Reality


“It was six men of Indostan
To learning much inclined,
Who went to see the Elephant(Though all of them were blind),
That each by observation
Might satisfy his mind”
- Verse 1 of Blind Man & the Elephant, John Godfrey Saxe

Our Man’s father is likely quite disappointed that he's quoting the John Godfrey Saxe poem (rather than say the version in Persian Sufi poet Sania's "The Walled Garden of Truth"), since the parable about “the blind men and an elephant” is of Indian origin.  The story tells of how 6 blind men come upon (or are introduced to) an elephant and each touch it to learn what it is like.  The men touch a different parts of the animal (side, tusk, trunk, knee, ear and tail) meaning that when they compare notes, each of them have a completely different (and incomplete) opinion of what an elephant is like.

The markets and global economy have offered a similar conundrum over the last 4-6 weeks, and like the blind men, there’s some evidence to support most perspectives. 

For example, the advance estimate of Q1-12’s real GDP growth (in the US) came in at +2.2%, a healthy enough number but beneath analyst estimates (of +2.5%) and the previous quarter (Q4-11: +3.0%).  On the surface, we should be pleased, after all GDP has now grown for 11 consecutive quarters.  Things seem less rosy when we consider a little more data and realize that the economy has only now returned to its 2007-peak and that historically-speaking, the pace of our post-recession growth is exceptionally slow.  This disappointment becomes clearer yet when we consider the extraordinary measures, including a zero-interest rate policy, massive budget deficits and the numerous attempts at unorthodox monetary policy (including QE1, QE2, QE-Lite, Operation Twist, etc), which have been used to try and stimulate the economy and drive growth.

And what to make of Europe?  The initial success of their unorthodox monetary policy (LTRO – where the ECB flooded European banks with cheap 3-year loans, and encouraged them to buy European sovereign debt with the money) was undeniable, silencing talk of potential crises in Italy and Spain by helping drive long-term bond yields substantially lower.  For example, Spanish 10-yr yields fell from over 6.7% in December to under 5% when the LTRO ended on 29th February.  Yet, barely 6-8 weeks later the same bond-yields are rising slowly back towards their pre-LTRO level and the worry is that LTRO has failed to buy enough time.  Furthermore, if the (admittedly British-centric view that) Euro was a political creation rather than an economic one, then the political carnage bears noting.  Every one of the PIIGS (Portugal, Ireland, Italy, Greece and Spain) has seen its government swept away, or replaced by unelected EU technocrats (e.g. PM Mario Monti in Italy, or PM Lucas Papedemos in Greece), irrespective of the previous ruling party’s history* and achievements.  Additionally, with politicians working not for their citizens but focused on defending the “Euro project”, nationalism (and the hard-Right and hard-Left) is on the rise not just in the PIIGS but in the core countries.  The last fortnight has seen Netherlands’ government collapse after the Freedom Party’s Geert Wilders brought down the coalition after openly calling for defiance against the "Diktats from Brussels".  Then there is France, where the National Front recorded their best ever election performance (17.9% of the vote) in the first round of voting and the recently formed Left Front (11% of the vote) almost doubled their share of the vote.

Finally, there’s China.  The last few weeks have seen a divergence between the different manufacturing PMI (Purchasing Managers Index) readings, with HSBC’s showing a continued slowdown and the official government one showing a decent bounce-back.  These readings followed the weaker than expected Q1 GDP Growth (+8.1%), which was the lowest reading since the end of the 08-recession.  While it’s clear that China’s growth has slowed, the prevailing attitude remains that the government remains accommodative and that the slowdown is contained and being managed with limited risk of a hard landing (GDP growth of <3%).  For the skeptics (including Our Man) however, the worries of falling house prices and the impacts of non-economic credit-driven investment continue to mount.

What does this all mean for Our Man?  Not much, as observers of the portfolio would recognize.  The opportunity to generate strong investment returns is at its peak when; (i) your perception of reality diverges significantly from the mainstream, (ii) you have high conviction that your perception accurately reflects reality and (iii) reality is likely to be acknowledged in the markets (or instruments you’re trading) within an acceptable time period.  This allows you to take risks that others feel imprudent and to do so in size, with some faith that if you’ve sized the positions appropriately (and in the right instruments) you can hold them until reality conforms to your perception (or your perception adjusts).  Today, Our Man’s issues is primarily temporal; I have a more bearish medium-term view of global growth (especially Chinese) than most and reasonable conviction in it, but more limited faith that the markets will conform to this view in the near-term.  As such, the portfolio continues to hold smaller (than optimal) positions that reflect my views and will allow it to participate should things change quickly, but also substantial amounts of cash that waits for greater clarity before being invested.



* To put this into context consider:  Ireland’s Fianna Fail, the largest party in the government in every election from 1932 to 2011, lost over 1/2 of its share of the vote and 3/4 of its seats in 2011.  Greece’s PASOK, which has dominated Greek government since the collapse of the country’s military dictatorship in 1974, are polling at 15% (vs. having never won less than 38% of the vote since 1981!) for Sunday’s election.
 

Wednesday, April 4

March 2012 Review


Portfolio Update
There were no changes to portfolio during March.

Performance Review
While March seemed superficially very similar to January and February there were some noticeable underlying differences, with Emerging Markets performing noticeably poorly led by Shanghai Stock Exchange Composite Index which fell over 6%.   In the US, the coincident macro data continued to be reasonable though showed signs of tailing off, while in Europe the markets rallied before relief over Greece’s deal with its creditors slowly waned over the course of the month.  Unfortunately, Our Man’s portfolio made no headway, falling 45bps (YTD: -1.8%).

The sources of the profits/losses during the month should not be surprising to regular readers.  The Puts/Hedge book (-38bps) and Treasuries book (-17bps) both suffered from the continued preference for risk assets in the US and were consistently negative contributors throughout the month.  Elsewhere, the Bond Funds (-6bps), China (-7bps) and Currencies (-3bps) were small negative contributors though all spent the majority of the month around the flat.  On the positive side, the NCAV book (+22bps) was the dominant contributor driven by the merger/takeover of one of the positions (OPXT) which alone lifted the entire book c15% in the final days of the month.  The Energy Efficiency book (+11bps) benefited largely from the market’s rise. 

The sole equity book that did not help performance was the Value Equities (-6bps), which also contributed negatively (about -26bps) over the quarter despite the market’s 10%+ rise.  While divergence from the indices is, of course, to be expected when the book contains a mere 2 names and is thus driven predominantly by idiosyncratic factors, both of the positions (THRX and DRWI) are down for the year.  While there were no major changes to the underlying fundamentals and news of either position, both have risks hanging over them that have yet to dissipate.  DRWI is scheduled to complete a transaction for Nokia-Siemens wireless business in the coming months, which while transformative for the company also brings with it execution risk as they turn their large pile of cash, into a revenue producing business that they have to integrate manage effectively.  THRX, together with its key partner GlaxoSmithKline, continues to work on trials and approval process for the compounds in its drug pipeline with regulatory submissions planned for a couple of programs.  Our Man’s sense is that for both these companies, it will be their success at managing these factors & processes that will largely determine their stock price moves over 2012 rather than the movements of the market.

Portfolio (as at 3/31 - all delta and leverage adjusted, as appropriate)
15.9% - Bond Funds (DLTNX and HSTRX)
5.2% - Value Idea Equities (THRX, and DRWI)
3.9% - Treasury Bonds (TLT)
2.3% - Energy Efficiency (AXPW, and XIDE)
1.7% - NCAV Equities
0.0% - Other Equities (none)

-1.9% - China-Related Thesis (40bps premium in EWZ Jan-13 puts)
-3.8% - Hedges/Put Options (22bps in IWM Jan-13 puts, 20bps in SPY Jan-13 puts and 15bps XLY Jan-13 puts)

-9.6% - Currencies (EUO – Short Euro)

65.2% - Cash

Disclaimer:  For added clarity, Our Man is invested in all of the securities mentioned (TLT, DLTNX, HSTRX, THRX, DRWI, AXPW, XIDE, , EWZ puts, IWM puts, SPY puts, XLY puts, and EUO).  He also holds some cash.  You should not buy any of these securities because Our Man has mentioned them, but should do your own work and decide what’s best for you.

Saturday, March 31

NCAV 2012-1


The first NCAV update of the year has been much delayed, as the process failed to show up any new names that could be added to the Absolute Value/NCAV bucket portfolio (for information on this bucket, and how it works, read here). 

While the initial screen is a valuable tool, a number of names were removed during the simple qualitative overlay;
- As Our Man has discussed previously, Chinese companies (listed in the US) that come up on the screen are currently being excluded due to the number of frauds within their ranks (see DGW, JGBO, Sino-Forest, Longtop Financial, etc  for just 4 examples over the last year or so) .  Like all screens, Our Man’s NCAV screen is reliant upon the quality of the data going into it and the number of recent Chinese-based frauds (whose stock is listed in the US) argues for their exclusion.
- A number of Financial companies were excluded, due to their different definition of Current Assets or the screen mistakenly using Total Assets (instead of Current Assets) to pass them.
- A number of companies were excluded as the data used in the screen was sufficiently dated to be of no great value (i.e. 2010 year-end data, which is now 15months out of date).

Like the last time the screen was run, one existing name (TWMC) reappeared on the screen.  As such, the final date that this name must be sold by has been extended (here are the rules when NCAV names are sold).   However, a number of existing positions (LTON, SUTR & XIN) are approaching the 366 day cut-off in the portfolio since last appearing in the NCAV screen and will thus be removed from the portfolio during April unless they reappear in the coming fortnight.  Finally, in the final week of March, OPXT agreed to a merger with Occlaro and unless any counter-bid is forthcoming (unlikely) in the coming weeks, this position will also be exited in April.  The sum of these changes will be to leave the NCAV Book at its smallest size since the inception of the portfolio, reflecting another (exceptionally unscientific) indication of the lack of absolute cheapness in market valuations.

Sunday, March 4

February 2012 Review

Portfolio Update
The changes to the portfolio during February came largely as result of rebalancing the book after some cash was added on Feb 1st.  This impacted the books in the following way:
- Bond Funds, China Thesis & Energy Efficiency books: The existing positions were all added to, and the size of these books was increased slightly.
- Value Equities & Currencies books: The existing positions were added to, and the size of the books was kept broadly unchanged.
- Hedges/Put Options:  The exposure and risk in the book was held broadly constant, but a new position in SPY (Jan-13) was added to the book in preference to adding to the existing positions.
- Treasury Bonds & NCAV books: The positions in these books were not added to, and so the size of the books was allowed to fall slightly.  In the case of the NCAV book, this was largely due to the small size of the positions in that book and it being uneconomical (given commission charges/etc) to add to them.

Performance Review
In many ways, February was a continuation of the risk-off trends seen during Q4 and which accelerated in January.  Coincident macro economic data continued to be reasonable, there was a tentative outline of an agreement between Greece and its creditors, and a China soft-landing is now seen as almost certain.  This again resulted in a rampant month for the markets but Our Man’s portfolio made no headway, falling 69bps (YTD: -1.4%).

However, unlike January when the portfolio moved broadly in-line with the market, February’s losses were far more event specific with performance driven by the Value Equities (+23bps) and Energy Efficiency books (-43bps).  While the long-term trends and potential for both positions in the Energy Efficiency book is favourable, the short-term continues to be tough and both were negative contributors with AXPW falling back after announcing an equity capital raise, and XIDE’s outlook disappointing investors.   Within the Value Equity book, the performance of the individual positions was better with THRX being a positive contributor and DRWI performing well, aided by generous market conditions and the prospect of some potential new contracts.

Elsewhere, the books that could be broadly called risk-off suffered led by Treasury Bonds (-11bps) and Puts/Hedges (-14bps), and the tentative agreement in Greece saw a rally in the Euro which hurt the Currencies book (-18bps).  However, the NCAV (-7bps), China thesis (-3bps) and Bond Funds (+3bps) were broadly flat over the month.

Portfolio (as at 2/29 - all delta and leverage adjusted, as appropriate)
15.9% - Bond Funds (DLTNX and HSTRX)
5.2% - Value Idea Equities (THRX, and DRWI)
4.1% - Treasury Bonds (TLT)
2.1% - Energy Efficiency (AXPW, and XIDE)
1.7% - NCAV Equities
0.0% - Other Equities (none)

-1.1% - China-Related Thesis (47bps premium in EWZ Jan-13 puts)
-3.6% - Hedges/Put Options (35bps in IWM Jan-13 puts, 33bps in SPY Jan-13 puts and 26bps XLY Jan-13 puts)

-9.6% - Currencies (EUO – Short Euro)

64.7% - Cash

Disclaimer:  For added clarity, Our Man is invested in all of the securities mentioned (TLT, DLTNX, HSTRX, THRX, DRWI, AXPW, XIDE, , EWZ puts, IWM puts, SPY puts, XLY puts, and EUO).  He also holds some cash.  You should not buy any of these securities because Our Man has mentioned them, but should do your own work and decide what’s best for you.

Saturday, February 18

Risk, Uncertainty, Opinion and Execution

Our Man hasn’t really written a post of substance in a while, for a mixture of good and bad reasons.  On one-hand, Our Man doesn’t really like to write when he has little of note or new to say, and on the other he spent most of the last 6 weeks obsessing over the Giant’s unlikely Super Bowl run!  However, with the Super Bowl clinched and the market partying like it is 1999…what better time to put down on paper some of the things that Our Man is pondering.

First, let’s take a step back and start on a philosophical note, and discuss the difference between risk and uncertainty as the two often become conflated when people talk about the markets.  To my mind, risk refers to an event (or series of events) that can cause a significant loss to the markets (market risk), or to one’s portfolio (portfolio risk).  Uncertainty is something different; it refers to a greater number of potential and viable pathways or routes for the market, some of which may entail great risk and others very limited risk.  What is important though is that because there are a greater number of viable pathways, the certainty that any particular one will be taken is low.  This means that the impact from small changes in information is magnified, because each change can be can easily extrapolated forwards as they new reality and thus change the markets potential route.  Of course, if the next piece of information contradicts the existing set, the probabilities change once more resulting in new potential routes.  While it’s tempting to assume that risk increases as things become more uncertain, that isn’t necessarily the case.

Secondly, in investing as with many other pursuits, it’s vitally important to separate out opinion from execution, and understand their relative importance.  While this sounds simple, in practice it’s somewhat more difficult – opinions are the most interesting part of being engaged on a subject, everyone has one and most aren’t shy about sharing them (irrespective of how well-formed they are)!  In short, people want to talk about (and listen to other peoples thoughts on) whether the market is going up, if Greece is going to exit the euro, will China have a hard landing, or are Eli Manning and Tom Coughlin certainties to make the Hall of Fame!  However, while opinion is interesting and fascinating, it’s what you do with those opinions (i.e. execution) that really matters.  Let’s imagine China were to have a hard landing; if you held this opinion in advance, that’s great but it’s not necessarily what makes you money – that’s driven by how you choose to express China hard landing (what companies/countries/etc, and what instruments), the resultant risk/reward of those choices, along with when you choose to put the trade on (is the hard landing coming in 2012, or 2013, or later…or should it have already come) and how you size it (if you’re too big too early, you may not be able to hold your position until the day it works, but too small or too late and you don’t make any money).  Unfortunately, while the sizing, timing and expression of a trade (i.e. the execution of an opinion) is what will drive returns, its importance is undervalued and largely ignored in the swirl of opinions.

So, why talk about this today?  Well, it’s a subject Our Man has touched on before and ponders a lot about, but it’s also one that has greater resonance today given Our Man’s skepticism and the market’s strong start to the year.  Opinion-wise, Our Man’s main skepticisms surround whether Europe is heading towards a long-term solution towards the sovereign debt issues, if the China-story is real or just another credit & investment-driven bubble, whether corporate margins are unsustainably high and if the US economy can continue to muddle-through.  Of these, the strength of the US economy is the one that the market has largely dismissed (though it’s doing its best to dismiss them all), as a result of the improving macro economic data that has come out with the consensus being that the US economy has hit escape velocity (again!).  Our Man would point out that while the leading data has been muted, most of the improving data has been coincident and lagging and thus extrapolating where we are now (or were yesterday) to project where we will be tomorrow is fraught with error, far smarter people have gone into far greater depth on this so he will leave you to read their words of wisdom

See, Our Man fell into the trap of wanting to talk about opinions, even after commenting on the frequency of such discussion.  So, enough about opinions, what about execution!  When talking about execution, Our Man will focus on the broad Equity books, the China thesis, and the Puts/Hedges books.  This is simply because the majority of the risk, and prospective returns, lie in these books - the Treasury Bonds and Bond Funds, which make up most of the exposure are unlikely to be a major driver of returns (either positively or negatively) except in extreme scenarios, and neither is the NCAV book or the position in the Euro*.  There is some other Equity risk in the portfolio, split largely between the Value Equities and Energy Efficiency books; in both cases it's relatively idiosyncratic, and invested in smaller more speculative names, hence the small position sizes to limit the potential losses.

So where does the main risk lie?  Well, as you know, Our Man's strongest opinions are his skepticism of China's growth and of the strength of both corporate earnings and the US economy.  Thus, unsurprisingly, the largest risks (and potential returns) are likely to be found in the Put/Hedge and the China Thesis books.  In both cases, Our Man's skepticism is expressed through out-of-the money put options; on Brazil (China Thesis) and on Market Indices and Consumer Stocks (Put/Hedge book).  Given the use of put options, the risk is easy to measure - the most the portfolio can lose over 2012 is the premium that Our Man has spent to buy these options (as they expire in Jan-13).  So far, Our Man has spent a total of 80bps on his China Thesis and 175bps in the Put/Hedge book, for a total of c250bps maximum loss (put premium) in 2012.  Again, impactful but not disastrously large amount should Our Man be wrong...however, I hope you noticed the "so far".  It matters because Our Man has mentally budgeted spending up to 500bps of put premium (i.e. a 5% maximum loss) in these two buckets, over the course of 2012.  To get there, it will require time, greater opportunity (or put another way, greater prospective return from each unit of risk) and higher conviction.  In practice, this is likely to come from a combination of higher stock prices (so that out-of-the money puts, struck at the same level as existing ones, become cheaper) and the underlying coincident data (on China, and/or the US economy/consumer) to hold steady or weaken.  This means, for example of the US-centric positions, the ideal scenario for Our Man is a market that rallies to 1,500 (S&P 500) while coincident economic/consumer/earnings data weakens, which would cause short-term loss on existing positions but the opportunity to add aggressively to them.  The main risks of course are that the coincident data continues to remain strong, the leading data improves and that the consumer and corporations prove resilient.  This is what Our Man has and will be watching in the coming weeks and months, to help him better execute on his bearish opinions.



* While the size of the Euro position looks relatively large (after adjusting for leverage), it would take an extreme scenario for it to be the major driver of performance.  For example, if we woke up tomorrow & the Euro was trading at its best point in 2011 (a move of 13% overnight), the loss would be c125bps…painful but not something that would ruin the portfolio.  By the same token, if it traded at its 2010 lows (a move of 10% overnight), the profit would be c100bps – once more, not something that would make a successful year.

Sunday, February 5

January 2012 Review


Portfolio Update
January saw only limited changes to the portfolio, and these changes largely reflected thoughts/themes that have been discussed previously and were already broadly expressed within the portfolio.
- China Thesis:  The FCX Jan-12 puts expired worthless but as expectations of a Chinese soft landing increased additional puts, on Brazil (EWZ Jan-13 puts), were added.
- Hedges/Put Options:  Despite the strong rally in Silver during the month, the SLV Jan-12 puts were sold in the early part of while they still had some value.  The book’s exposure was largely retained, as some puts on the Consumer Discretionary ETF (XLY Jan-13 puts) were added.

Performance Review
January saw the coincident macro economic data showing continued signs of improving (especially in the US), hopes for an agreement between Greece and its creditors, and a increased expectations of a Chinese soft landing.  While this resulted in a rampant January for the markets, it wasn’t so kind to Our Man’s portfolio which fell 71bps (YTD: -0.71%).

Unsurprisingly, given the strength of the market, the majority of the books that contributed (both positively and negatively) were equity-focused.  Both the Puts/Hedges book (-89bps) and the China-Related book (-32bps) suffered from the rise in equity markets and the related fall in market volatility.  Against this, the NCAV book (+24bps) rose strongly as the reduction in uncertainty benefited the small-cap holdings that make up the book.  The Energy Efficiency book (+57bps) was the strongest contributor to performance, with the position in XIDE rising 26% benefiting from the increased willingness of the market to accept risk and additional time for shareholders to better understand and put into contextthe disappointing November disclosures.  However, the main driver was the Value Equities book (-43bps); while the position in DRWI was a positive contributor, the THRX position cost over 50bps.  THRX’s weakness was largely driven by mixed phase III study results for its primary drug (Revolair, which is being developed in conjunction with Glaxo) and subsequent downgrades from brokers.

In the non-Equity books, the contributions were more muted.  The Treasury Bonds book was flat (-<0bps) and the Currency book (-13bps) was down slightly as hopes grew in the latter part of the month for a settlement between Greece and its creditors.  The Bond Funds (+26bps) again contributed positively, with positions in mortgage-related securities (DLTNX) and precious metals-related securities (HSTRX) helping contribute to performance.  The Currencies book (-13bps) posted a small loss, following a rally in the Euro in the second half of the month, as hopes grew for a deal between Greece and its creditors.

Portfolio (as at 1/31 - all delta and leverage adjusted, as appropriate)
14.9% - Bond Funds (DLTNX and HSTRX)
4.9% - Treasury Bonds (TLT)
4.8% - Value Idea Equities (THRX, and DRWI)
2.1% - NCAV Equities
2.3% - Energy Efficiency (AXPW, and XIDE)
0.0% - Other Equities (none)

-0.9% - China-Related Thesis (39bps premium in EWZ Jan-13 puts)
-3.7% - Hedges/Put Options (48bps in IWM Jan-13 puts and 39bps XLY Jan-13 puts)

-10.0% - Currencies (EUO – Short Euro)

64.7% - Cash

Disclaimer:  For added clarity, Our Man is invested in all of the securities mentioned (TLT, DLTNX, HSTRX, THRX, DRWI, AXPW, XIDE, , EWZ puts, IWM puts, XLY puts, and EUO).  He also holds some cash.  You should not buy any of these securities because Our Man has mentioned them, but should do your own work and decide what’s best for you.